VEGF levels in humans and animal models with RDS and BPD: temporal relationships

Area of Science:

• Neonatal Medicine
• Pulmonary Biology
• Developmental Biology

Background:

• Respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD) are major causes of neonatal illness and death.
• Pulmonary function relies on the interplay between alveolar microvasculature and airspace development.
• The role of vascular endothelial growth factor (VEGF) in neonatal respiratory failure is not fully understood, with conflicting data from animal and human studies.

Purpose of the Study:

• To highlight the significance of the temporal relationship between VEGF and lung development.
• To emphasize the importance of developmentally-appropriate animal models for studying human neonatal lung diseases like RDS and BPD.

Main Methods:

• Review of existing literature on VEGF, lung development, RDS, and BPD.
• Analysis of animal models and human studies.
• Focus on the temporal aspects of VEGF expression during lung development.

Main Results:

• VEGF levels increase during normal lung development in animal models.
• Controversial results exist regarding VEGF's pathophysiological role in neonatal respiratory failure.
• Differences in physiology between species necessitate careful timing of animal studies.

Conclusions:

• Accurate correlation of animal models with human lung development requires careful consideration of study timing.
• Further research is needed to clarify the precise role of VEGF in neonatal RDS and BPD.
• Optimizing animal models by considering developmental timelines is crucial for advancing our understanding of these conditions.